Your browser is no longer supported. Please, upgrade your browser.
PRGO Perrigo Company Public Limited Company monthly Stock Chart
PRGO [NYSE]
Perrigo Company Public Limited Company
IndexS&P 500 P/E123.22 EPS (ttm)1.50 Insider Own0.05% Shs Outstand146.26M Perf Week-2.41%
Market Cap27.03B Forward P/E20.73 EPS next Y8.92 Insider Trans-16.51% Shs Float145.59M Perf Month-4.23%
Income203.40M PEG8.98 EPS next Q2.00 Inst Own74.30% Short Float0.97% Perf Quarter11.72%
Sales4.22B P/S6.41 EPS this Y-62.00% Inst Trans-1.91% Short Ratio0.68 Perf Half Y10.37%
Book/sh68.08 P/B2.71 EPS next Y16.54% ROA2.00% Target Price204.40 Perf Year27.16%
Cash/sh23.60 P/C7.83 EPS next 5Y13.72% ROE3.30% 52W Range134.71 - 215.59 Perf YTD10.73%
Dividend0.50 P/FCF32.32 EPS past 5Y3.10% ROI2.80% 52W High-14.36% Beta0.23
Dividend %0.27% Quick Ratio3.50 Sales past 5Y15.20% Gross Margin35.60% 52W Low37.06% ATR3.86
Employees10220 Current Ratio4.00 Sales Q/Q4.50% Oper. Margin17.40% RSI (14)42.81 Volatility1.90% 1.84%
OptionableYes Debt/Eq0.49 EPS Q/Q-286.10% Profit Margin7.10% Rel Volume0.40 Prev Close184.83
ShortableYes LT Debt/Eq0.46 EarningsMay 04 BMO Payout19.60% Avg Volume2.09M Price184.64
Recom2.30 SMA20-1.92% SMA50-3.35% SMA20010.26% Volume706,733 Change-0.10%
Jun-03-15Reiterated B. Riley & Co. Neutral $195 → $216
Apr-27-15Downgrade B. Riley & Co. Buy → Neutral
Apr-22-15Reiterated B. Riley & Co. Buy $189 → $195
Apr-10-15Downgrade Argus Buy → Hold
Feb-06-15Reiterated RBC Capital Mkts Outperform $177 → $175
Nov-12-14Reiterated Argus Buy $160 → $175
Nov-07-14Reiterated RBC Capital Mkts Outperform $169 → $177
Sep-22-14Reiterated RBC Capital Mkts Outperform $160 → $169
May-15-14Reiterated Argus Buy $175 → $160
May-08-14Reiterated B. Riley & Co. Neutral $170 → $157
May-08-14Downgrade RBC Capital Mkts Top Pick → Outperform $187 → $160
Mar-03-14Reiterated UBS Buy $176 → $190
Mar-03-14Reiterated Stifel Buy $165 → $175
Feb-25-14Reiterated CRT Capital Buy $165 → $175
Feb-07-14Downgrade B. Riley & Co. Buy → Neutral
Jan-16-14Reiterated Argus Buy $160 → $175
Jan-07-14Initiated RBC Capital Mkts Top Pick $187
Dec-12-13Reiterated Stifel Buy $150 → $165
Nov-07-13Reiterated Argus Buy $152 → $160
Nov-04-13Reiterated UBS Buy $140 → $160
Jul-01-15 02:34PM  History Tells Jacob Gottlieb His Top 3 Large-Cap Positions Beat The Market at Insider Monkey
01:13PM  Top Takeaways From BMO's Specialty Pharma Day
Jun-30-15 11:48AM  A New Rider in the Perrigo, Mylan, Teva Merger Merry-Go-Round at Barrons.com
Jun-29-15 06:37PM  Boehringer's Roxane Labs draws bid from Hikma, Mallinckrodt- Bloomberg
Jun-25-15 12:00PM  EU regulators to rule on Mylan bid for Perrigo by July 29 Reuters
Jun-24-15 09:07AM  Mylan eyes Tel Aviv listing if Perrigo deal goes ahead Reuters
03:07AM  Edited Transcript of PRGO presentation 23-Jun-15 3:45pm GMT
Jun-23-15 12:10PM  Perrigo Going Up With Or Without Mylan, Says BMO at Investor's Business Daily
08:16AM  Mylan CFO to meet Tel Aviv bourse chief to discuss listing - source Reuters
Jun-22-15 01:30PM  Teva Announces Acquisition of 4.61% Interest in Mylan - Analyst Blog
Jun-19-15 09:30AM  Teva gains standing to challenge Mylan poison pill at bizjournals.com
09:07AM  Teva takes 4.6 percent stake in Mylan as part of bid
08:53AM  Teva Takes 4.6% Stake in Mylan at The Wall Street Journal
Jun-18-15 05:20PM  Teva ups Mylan stake, handed setback in court ruling at bizjournals.com
03:16PM  Teva Bid for Mylan Could Be 'Imminent' at Barrons.com
Jun-17-15 04:50PM  Mylan Inks Deal with Pulmatrix for Respiratory Disease Drug - Analyst Blog
12:17PM  Volatility Marks the Day for US Markets on June 16
12:49AM  Edited Transcript of PRGO presentation 12-May-15 8:00pm GMT
Jun-16-15 08:01PM  Abbott Backs Mylan and Its Strategy to Buy Perrigo at TheStreet
07:52PM  Business Watch at The Wall Street Journal
05:06PM  Stocks End Near Highs; Perrigo Rebounds On Mylan Deal at Investor's Business Daily
04:59PM  Adobe shares slide after hours on weak outlook at MarketWatch
03:39PM  Teva's Auspex Buyout Pays, But Mylan Bid Hits Snag at Investor's Business Daily
11:25AM  Mylan's largest shareholder Abbott Laboratories backs in Perrigo bid at bizjournals.com
10:11AM  Abbott to Vote in Favor of Mylan's Perrigo Deal at The Wall Street Journal
09:20AM  Abbott to vote for Mylan's acquisition of Perrigo
09:19AM  Mylan Issues Statement in Response to Abbott's Support for Perrigo Transaction PR Newswire
09:17AM  Abbott Will Back Mylans Perrigo Bid Using 14.5% Share Stake at Bloomberg
Jun-10-15 06:14PM  Aberdeen Fund Manager Sees Israeli Stocks Pushed by Strong Economy at TheStreet
Jun-08-15 02:30PM  Teva again increases share in Mylan N.V. at bizjournals.com
01:07PM  Teva accuses Mylan of 'desperate attempt' to suppress bid
12:15PM  Teva fires back at Mylan chairmans criticism of proposed takeover at bizjournals.com
Jun-03-15 03:32PM  Perrigo to Buy OTC Brands from GlaxoSmithKline in Europe - Analyst Blog
Jun-02-15 05:37PM  Dealpolitik: Hand-to-Hand Combat as Teva/Mylan Showdown Approaches at The Wall Street Journal
04:45PM  Perrigo Buys GlaxoSmithKline, Novartis Consumer Medicines at TheStreet
01:59PM  Perrigo Plays European Defense at The Wall Street Journal
01:08PM  Will Perrigo's Glaxo Buy Make It Too Pricey? at Investor's Business Daily
10:00AM  Perrigo expands its drug portfolio
09:41AM  Faber Report: Mylan sends letter to Teva
08:45AM  Five things to know today, and Perrigo doesn't sound like a company that thinks it'll be acquired at bizjournals.com
07:48AM  Early movers: MDT, PVH, DG, SHLD, AAPL & more at CNBC
07:00AM  Actavis And Perrigo Receive FDA Approval Of Guaifenesin/Pseudoephedrine, The Store Brand Equivalent To Mucinex┬« D Tablets PR Newswire
06:27AM  Perrigo To Acquire Portfolio Of Leading OTC Brands From GSK PR Newswire
Jun-01-15 06:39PM  Mylan tells Teva to 'stop playing games' at Financial Times
04:40PM  Mylan executive chairman tells Teva to stop meddling in its affairs at bizjournals.com
08:20AM  3 Specialty Pharma Stocks That Could Be Acquired in 2015 at 24/7 Wall St.
May-29-15 05:31PM  Actavis PLC (ACT), Laboratory Corp. of America Holdings (LH) Among Health Fund Visiums Top Picks at Insider Monkey
12:25PM  Teva buying up shares of Mylan at bizjournals.com
May-27-15 04:13PM  Perrigo Company To Present At The Jefferies 2015 Healthcare Conference PR Newswire
May-26-15 12:20PM  Exclusive: Mylan chairman says Teva offers nothing we can't do on our own at bizjournals.com
08:05AM  Five things to know today, and why Mylan NV didn't take a holiday at bizjournals.com
May-25-15 09:47AM  Mylan/Perrigo Clarification PR Newswire
08:02AM  Considering the Investment Impact of Baby Boomers Retirement
May-21-15 04:02PM  Energy Stocks Dominating Billionaire Izzy Englanders Top Holdings: NextEra Energy Inc (NEE), Noble Energy, Inc. (NBL), Devon Energy Corp (DVN) at Insider Monkey
May-20-15 09:29AM  10 S&P 500 Companies to Have the Most Revenue Growth in 2015 at TheStreet
May-19-15 07:31PM  Mariko Gordon Sells Lumber Liquidators, Western Digital
08:19AM  Five things to know today, and a big golden parachute in Heinz merger at bizjournals.com
May-18-15 01:37PM  Perrigo CEO Says Ready to Talk Deal With Mylan at Right Price at Bloomberg
10:38AM  Endo Buying Par Pharma To Become Top Generics Player at Investor's Business Daily
07:39AM  How to play weak Q2 earnings season: Analysts at CNBC
May-13-15 11:50AM  Perrigo (PRGO) Buys Patheon's Mexican Business for $34M - Analyst Blog
May-12-15 03:23PM  Perrigo expands Mexican business in $34M deal with Pantheon
12:04PM  Perrigo Company To Present At The UBS Global Healthcare Conference PR Newswire
11:42AM  Pharma M&A: Taking stock at Financial Times
09:25AM  Perrigo to Buy Patheon's Mexican Business at The Wall Street Journal
09:06AM  Mylans Share Price Declines 3% on 1Q15 Earnings
08:45AM  Perrigo Acquires Patheon's Mexican Operations PR Newswire
May-11-15 06:36PM  Actavis Earnings Strong, Gives 2015 Guidance
09:05AM  The Many Reasons Mylan Is So Keen to Acquire Perrigo
05:04AM  What Is the Risk-to-Reward on the PerrigoMylan Situation?
04:05AM  How the Mylan Bid Stacks Up to Similar Transactions
04:04AM  Whats the Spread in the PerrigoMylan transaction?
May-08-15 05:00PM  Dealpolitik: Mylan to Investors: We'll Do What We Want at The Wall Street Journal
12:20PM  Horizon Pharma Q1 Mixed, Settles Suit With Perrigo at Investor's Business Daily
May-07-15 05:39PM  Jim Chanos, Kyle Bass Rip Oil And Pharma At SALT 2015
11:12AM  EXCLUSIVE: Hedge funder Kyle Bass is at war with big pharma, but he's long on this one pharma stock
May-06-15 09:42AM  Faber Report: Mylan pushes for Perrigo
07:51AM  Early movers: GEVA, MGI, JPM, WEN, NWSA & more at CNBC
May-05-15 10:01AM  Perrigo Animal Health Launches PetArmor┬« Joint Health Maximum Supplement for Dogs PR Newswire
May-04-15 04:00PM  Can Mylan (MYL) Specialty Segment Secure Earnings Beat? - Analyst Blog
07:07AM  Q3 2015 Perrigo Company PLC Earnings Release - Before Market Open
May-01-15 02:38PM  Top picks in health care
Apr-30-15 04:57PM  Perrigo Company To Present At Upcoming Healthcare Conferences at noodls
04:27PM  Perrigo Company To Present At Upcoming Healthcare Conferences PR Newswire
04:25PM  Analyst: Mylan Shareholders Might Get Convinced By Vigodman Letter
12:29AM  Mylan Should Try Teva On for Size at The Wall Street Journal
Apr-29-15 06:42PM  Perrigo rejects raised Mylan bid; Teva recommits to Mylan buy
05:40PM  Takeover target triangle: Teva, Mylan & Perrigo
04:44PM  Mylan Raises Its Offer for Generics Counterpart Perrigo at TheStreet
02:36PM  Mylan Should Try Teva On for Size at The Wall Street Journal
01:29PM  Mylan ups Perrigo bid again and gets rejected at MarketWatch
01:29PM  Perrigo Rejects Mylans Increased Offer
01:18PM  Mylan Bumps Up Offer for Perrigo
01:03PM  The PerrigoMylan Proposal Faces some Big Hurdles
01:03PM  Mylan Launches Hostile Bid for Perrigo
12:40PM  Starwood Hotels Explores Possible Sale, and More at MarketWatch
12:33PM  Perrigo rebuffs sweetened $35.6bn offer from Mylan at Financial Times
12:28PM  Mylan Raises Perrigo Bid, But Perrigo Still Says No at Investor's Business Daily
11:56AM  Mylan Boosts Offer for Perrigo to $35.6 Billion at The Wall Street Journal
11:21AM  Perrigo Rejects Latest Mylan Unsolicited Offer at noodls
Perrigo Company plc, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API). Its Consumer Healthcare segment offers OTC pharmaceutical products in the areas of analgesics, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, and animal health products, as well as in the areas of feminine hygiene, diabetes care, and dermatological care; and contract manufacturing services. The company's Nutritionals segment offers infant and toddler formula products, infant and toddler foods, as well as vitamins, minerals, and dietary supplement products to retailers, distributors, and consumers. Its Rx Pharmaceuticals segment develops, manufactures and markets a portfolio of Rx drugs in topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, and powders, as well as controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. This segment provides its products to chain drug stores, wholesalers, distributors, hospital systems, and group purchasing organizations. The company's API segment develops, manufactures, and markets API that are used in the production of pharmaceutical products to generic drug industries and branded pharmaceutical companies. Its Specialty Sciences segment provides Tysabri, which is used for the treatment of Multiple Sclerosis; and Prialt, a non-narcotic intrathecal analgesic. The company also offers pharmaceutical and medical diagnostic products. The company offers its products primarily in the United States, the United Kingdom, Mexico, Israel, and Australia, as well as in Canada, China, and Latin America. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KINGMA TODD WExecutive VP, General CounselApr 29Option Exercise58.821,70099,99411,064May 01 04:19 PM
KINGMA TODD WExecutive VP, General CounselApr 29Sale190.271,700323,4599,364May 01 04:19 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyApr 14Option Exercise107.058,800941,9974,148Apr 16 04:14 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyApr 14Sale200.278,8001,762,3760Apr 16 04:14 PM
KINGMA TODD WExecutive VP, General CounselApr 13Option Exercise35.851,30046,60510,664Apr 15 02:57 PM
KINGMA TODD WExecutive VP, General CounselApr 13Sale198.441,300257,9729,364Apr 15 02:57 PM
Shah JatinSr VP & Chief Scientific OfficMar 13Sale165.502,000331,0003,291Mar 17 10:50 AM
Yu LouisExecutive VP Global QualityMar 12Sale166.2714023,2784,746Mar 16 04:35 PM
Farrington ThomasSenior VP and CIOFeb 20Sale151.1851778,161321Feb 24 04:26 PM
Farrington ThomasSenior VP and CIOFeb 06Option Exercise0.0079801,119Feb 09 04:37 PM
MORRIS HERMAN JRDirectorNov 14Sale154.4220030,8831,400Nov 17 05:22 PM
Kochan SharonEVP, GM InternationalNov 10Option Exercise90.655,367486,51910,767Nov 12 04:37 PM
Kochan SharonEVP, GM InternationalNov 10Sale156.365,367839,1845,400Nov 12 04:37 PM
Yu LouisExecutive VP Global QualityNov 10Sale155.1125940,1734,886Nov 12 04:33 PM
Brown Judy LExecutive VP & CFONov 03Option Exercise48.923,515171,9539,445Nov 05 04:39 PM
Brown Judy LExecutive VP & CFONov 03Sale160.603,515564,5077,445Nov 05 04:39 PM
Brown Judy LExecutive VP & CFOOct 01Option Exercise48.923,515171,9539,445Oct 02 04:26 PM
Brown Judy LExecutive VP & CFOOct 01Sale150.723,515529,7817,445Oct 02 04:26 PM
Kochan SharonEVP, GM InternationalSep 03Sale150.001,116167,4005,400Sep 04 04:42 PM
KINGMA TODD WExecutive VP, General CounselSep 03Sale150.101,000150,0952,000Sep 03 05:00 PM
Farrington ThomasSenior VP and CIOSep 02Sale150.361,741261,773321Sep 03 05:12 PM
KINGMA TODD WExecutive VP, General CounselAug 29Option Exercise35.851,25044,81310,614Sep 03 05:00 PM
KINGMA TODD WExecutive VP, General CounselAug 29Sale149.301,250186,6259,364Sep 03 05:00 PM